Company Sigilon Therapeutics, Inc.
Equities
SGTX
US82657L2060
Biotechnology & Medical Research
Business Summary
Number of employees: 62
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 60 | 18-08-13 | |
Director of Finance/CFO | 58 | 19-10-31 | |
Philip Johnson
PSD | President | 59 | 23-08-10 |
Bernd Kullmann
COO | Chief Operating Officer | - | - |
Qing Sarah Yuan
CTO | Chief Tech/Sci/R&D Officer | 53 | 22-03-06 |
Chief Tech/Sci/R&D Officer | 60 | 21-06-13 | |
Chief Administrative Officer | 52 | 18-12-31 | |
Michael Thompson
BRD | Director/Board Member | - | 23-08-10 |
Robert Windsor
IRC | Investor Relations Contact | - | 21-04-30 |
Chris Anderson
SEC | Corporate Secretary | - | 23-08-10 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 60 | 18-08-13 | |
Philip Johnson
PSD | President | 59 | 23-08-10 |
Gordon Brooks
BRD | Director/Board Member | - | 23-08-10 |
Michael Thompson
BRD | Director/Board Member | - | 23-08-10 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,502,084 | 2,294,190 ( 91.69 %) | 0 | 91.69 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |